Greenwood Capital Associates Llc
Source: SEC Form 13F · as of Mar 2026Greenwood Capital Associates Llc holds 19 biotech & pharma companies tracked by BioSniper, totaling $68.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$68.4M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 47,170 | $11.5M |
| LLYELI LILLY & Co | 12,014 | $11.0M |
| AMGNAMGEN INC | 30,444 | $10.7M |
| REGNREGENERON PHARMACEUTICALS, INC. | 11,261 | $8.7M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 22,013 | $6.0M |
| TEVATeva Pharmaceutical Industries Limited | 180,398 | $5.4M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 12,101 | $5.4M |
| BMYBRISTOL MYERS SQUIBB CO | 33,409 | $2.0M |
| PFEPFIZER INC | 55,999 | $1.6M |
| MRKMerck & Co., Inc. | 9,992 | $1.2M |
| ABBVAbbVie Inc. | 5,321 | $1.2M |
| GMEDGlobus Medical Inc. | 7,909 | $681K |
| NVONovo Nordisk A/S | 14,451 | $531K |
| MOHMolina Healthcare Inc | 3,865 | $515K |
| PCRXPacira BioSciences, Inc. | 22,795 | $515K |
| HALOHALOZYME THERAPEUTICS, INC. | 7,720 | $499K |
| MDGLMADRIGAL PHARMACEUTICALS, INC. | 682 | $357K |
| INCYIncyte Corp. | 3,343 | $315K |
| KRYSKrystal Biotech, Inc. | 834 | $215K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.